Randall Whitcomb is listed as a director on 6 SEC Form D filings by 1 issuer between Apr 2012 and Dec 2017: Millendo Therapeutics, Inc. (Ann Arbor, MI — pharmaceuticals — 2012–2017; $50M reported sold to 21 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside James Topper (6 shared filings), Julia C. Owens (6 shared filings), Carol Gallagher (4 shared filings), Raili Kerppola (3 shared filings), Andrew Schwab (2 shared filings) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Randall. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 6 public filings for Randall Whitcomb and found 6 differences: Form D filed 17 days after the first sale; 4 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
